Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2026

In 2026, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 17.67% of shares outstanding on 15 Jan 2026 to 17.43% on 15 Sep 2026, a change of -0.24 percentage points. The year's high was 20.04% on 14 Aug 2026 and its low 13.47% on 13 Mar 2026, averaging 16.91% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.80 days on 29 May 2026. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2026

2026 in figures

Start of year
17.67% (15 Jan 2026)
End of year
17.43% (15 Sep 2026)
Change
-0.24 pp
High
20.04% (14 Aug 2026)
Low
13.47% (13 Mar 2026)
Average
16.91%
Highest days to cover
17.80 (29 May 2026)
SEC filings marked
6

Every report in 2026

COLLEGIUM PHARMACEUTICAL, INC short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202617.67%10.81
30 Jan 202615.17%9.43
13 Feb 202615.03%15.75
27 Feb 202614.48%12.9910-K filed, results (8-K)
13 Mar 202613.47%7.39
31 Mar 202617.42%7.85
15 Apr 202619.00%10.74
30 Apr 202618.30%14.44
15 May 202618.39%11.1810-Q filed, results (8-K)
29 May 202617.46%17.80
15 Jun 202616.43%13.07
30 Jun 202616.85%10.84
15 Jul 202616.14%11.19
31 Jul 202615.61%17.35
14 Aug 202620.04%6.6610-Q filed, results (8-K)
31 Aug 202618.63%8.08
15 Sep 202617.43%6.03

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.